Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-28 Sale | 2025-10-30 6:40 pm | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 400,408 | $25.9 | $10,368,938 | 779,652 (Indirect) | View |
| 2025-10-23 Sale | 2025-10-27 8:04 pm | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 221,166 | $28.06 | $6,204,863 | 1,180,060 (Indirect) | View |
| 2025-10-20 Sale | 2025-10-22 7:48 pm | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 117,050 | $29.34 | $3,433,992 | 1,401,226 (Indirect) | View |
| 2025-10-17 Sale | 2025-10-21 5:45 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 37,533 | $30.19 | $1,133,103 | 1,166,909 (Direct) | View |
| 2025-10-15 Sale | 2025-10-17 6:33 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 73,676 | $31.88 | $2,348,744 | 1,204,442 (Direct) | View |
| 2025-10-15 Sale | 2025-10-17 6:03 pm | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 464,025 | $29.54 | $13,707,361 | 15,104 (Indirect) | View |
| 2025-10-10 Sale | 2025-10-15 6:32 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 96,657 | $31.08 | $3,003,706 | 1,278,118 (Direct) | View |
| 2025-10-08 Sale | 2025-10-10 5:51 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 124,146 | $33.16 | $4,116,369 | 1,374,775 (Direct) | View |
| 2025-10-06 Sale | 2025-10-08 5:20 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 98,387 | $36.12 | $3,553,499 | 1,498,921 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 9:12 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 41,752 | $39.43 | $1,646,237 | 1,597,308 (Direct) | View |
| 2025-09-16 Sale | 2025-09-18 8:40 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 447,278 | $1.5401 | $688,853 | 32,781,209 (Direct) | View |
| 2025-09-11 Sale | 2025-09-15 5:17 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 984,805 | $1.7303 | $1,703,971 | 33,228,487 (Direct) | View |
| 2025-09-08 Sale | 2025-09-10 8:27 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 1,263,647 | $1.9451 | $2,457,975 | 34,213,292 (Direct) | View |
| 2025-09-03 Sale | 2025-09-05 6:51 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 1,407,628 | $1.9664 | $2,767,982 | 35,476,939 (Direct) | View |
| 2025-08-27 Sale | 2025-08-29 6:05 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 1,417,998 | $2.0088 | $2,848,511 | 36,884,567 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 5:25 pm | Vor Biopharma Inc. | VOR | Reprogrammed Interchange LLC Hoffman Reid 10% Owner | 671,536 | $2.1013 | $1,411,083 | 38,302,565 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-18 Option Award | 2025-09-22 4:56 pm | N/A N/A | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 10,000,000 | $5 | 10,000,000 (Indirect) | View |
| 2025-09-08 Option Award | 2025-09-10 4:15 pm | N/A 2035-09-07 | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 60,000 | $0 | 60,000 (Indirect) | View |
| 2025-09-08 Option Award | 2025-09-10 4:10 pm | N/A 2035-09-07 | Vor Biopharma Inc. | VOR | Reed Sarah Burgess Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-07-17 Option Award | 2025-07-30 4:03 pm | N/A 2035-07-16 | Vor Biopharma Inc. | VOR | Zuraw Qing Che Chief Development Officer | 5,310,120 | $0 | 5,310,120 (Direct) | View |
| 2025-07-16 Option Award | 2025-07-18 5:16 pm | N/A 2035-07-15 | Vor Biopharma Inc. | VOR | Detheux Michel Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-07-16 Option Award | 2025-07-18 5:14 pm | N/A 2035-07-15 | Vor Biopharma Inc. | VOR | Cumbo Alexander Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-07-09 Option Award | 2025-07-10 4:51 pm | N/A N/A | Vor Biopharma Inc. | VOR | Mahatme Sandesh CFO | 13,882,750 | $0 | 13,882,750 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-27 4:10 pm | N/A 2035-06-25 | Vor Biopharma Inc. | VOR | Kress Jean-Paul CEO and Chairman | 83,296,638 | $0 | 83,296,638 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 5:47 pm | N/A 2035-05-21 | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 30,000 | $0 | 30,000 (Indirect) | View |
| 2025-05-22 Option Award | 2025-05-23 5:45 pm | N/A 2035-05-21 | Vor Biopharma Inc. | VOR | Resnick Joshua Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 5:45 pm | N/A 2035-05-21 | Vor Biopharma Inc. | VOR | Kalir Erez Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 5:45 pm | N/A 2035-05-21 | Vor Biopharma Inc. | VOR | Lundberg Sven Ante Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 5:45 pm | N/A 2035-05-21 | Vor Biopharma Inc. | VOR | Lubner David Charles Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 5:45 pm | N/A 2035-05-21 | Vor Biopharma Inc. | VOR | Beckman Daniella Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 5:45 pm | N/A 2035-05-21 | Vor Biopharma Inc. | VOR | Patterson Matthew R Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 5:45 pm | N/A 2035-05-21 | Vor Biopharma Inc. | VOR | Namouni Fouad Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-05-06 Tax Withholding | 2025-05-07 4:05 pm | N/A N/A | Vor Biopharma Inc. | VOR | ANG ROBERT PRESIDENT AND CEO | 2,361 | $0.56 | 911,318 (Direct) | View |
| 2025-05-06 Tax Withholding | 2025-05-07 4:05 pm | N/A N/A | Vor Biopharma Inc. | VOR | Chakraborty Tirtha Chief Sci Off & Head Tech Ops | 876 | $0.56 | 217,416 (Direct) | View |